Cellular turnover and extracellular matrix remodeling in female reproductive tissues: Functions of metalloproteinases and their inhibitors

Cellular and Molecular Life Sciences

Volumn 57, Issue 1, 2000, Pages 77-95

  Fata, J E ^a   Ho, A T V ^a   Leco, K J ^a   Moorehead, R A ^a   Khokha, R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

ECM; Mammary tissue; MMPs; Ovary; TIMPs; Uterus

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

BREAST; BREAST CARCINOMA; CELL KINETICS; CELL MATURATION; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; OVARY; OVARY CARCINOMA; REVIEW; UTERUS;

EID: 0033975272     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050500     Document Type: Review

References (194)

1. 1 Gross J. and Lapière C. M. (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. USA 48: 1010-1022
2. 2 Cawston T. E., Galloway W. A., Mercer E., Murphy G. and Reynolds J. J. (1981) Purification of rabbit bone inhibitor of collagenase. Biochem. J. 195: 159-165
3. 3 Murphy G., Cawston T. E. and Reynolds J. J. (1981) An inhibitor of collagenase from human amniotic fluid: purification, characterization and action on metalloproteinases. Biochem. J. 195: 167-170
4. 4 Stricklin G. P. and Welgus H. G. (1983) Human skin fibroblast collagenase inhibitor: purification and biochemical characterization. J. Bid. Chem. 258: 12252-12258
5. 5 Golde D. W., Bersch N., Quan S. G. and Lusis A. J. (1980) Production of erythroid-potentiating activity by a human T-lymphoblast cell line. Proc. Natl. Acad. Sci. USA 77: 593-596
6. 6 Gasson J. C., Golde D. W., Kaufman S. E., Westbrook C. A., Hewick R. M., Kaufman R. J. et al. (1985) Molecular characterization and expression of the gene encoding human crythroid-potentiating activity. Nature 315: 768-771
7. 7 Docherty A. J., Lyons A., Smith B. J., Wright E. M., Stephens P. E., Harris T. J. et al. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318: 66-69
8. 8 Edwards D. R., Waterhouse P., Holman M. L. and Denhardt D. T. (1986) A growth-responsive gene (I6C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducibie and constitutive transcripts. Nucleic Acids Res. 14: 8863-8878
9. 9 Gewert D. R., Coulombe B., Castelino M.. Skup D. and Williams B. R. (1987) Characterization and expression of a murine gene homologous to human EPA/TIMP: a virus-induced gene in the mouse. EMBO J. 6: 651-657
10. 10 Avalos B. R., Kaufman S. E., Tomonaga M., Williams R. E., Golde D. W. and Gasson J. C. (1988) K562 cells produce and respond to human erythroid-potentiating activity. Blood 71: 1720-1755
11. 11 Stetler-Stevenson W. G., Brown P. D., Onisto M., Levy A. T. and Liotta L. A. (1990) Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265: 13933-13938
12. 12 Boone T. C., Johnson M. J., De C. Y. and Langley K. E. (1990) cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc. Natl. Acad. Sci. USA 87: 2800-2804
13. 13 Stetler-Stevenson W. G., Bersch N. and Golde D. W. (1992) Tissue inhibitor of melalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett. 296: 231-234
14. 14 Pavloff N., Staskus P. W., Kishnani N. S. and Hawkes S. P. (1992) A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J. Biol. Chem. 267: 17321-17326
15. 15 Apte S. S., Mattei M. G. and Olsen B. R. (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 19: 86-90
16. 16 Wick M., Haronen R., Mumberg D., Burger C., Olsen B. R., Budarf M. L. et al. (1995) Structure of the human TIMP-3 gene and its cell cycle-regulated promoter. Biochem. J. 311: 549-554
17. 17 Silbiger S. M., Jacobsen V. L., Cupples R. L. and Koski R. A. (1994) Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene 141: 293-297
18. 18 Una J. A., Ferrando A. A., Velasco G., Freije J. M. and Lopez-Otin C. (1994) Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 54: 2091-2094
19. 19 Leco K. J., Khokha R., Pavloff N., Haukes S. P. and Edwards D. R. (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360
20. 20 Apte S. S., Hayashi K., Seldin M. F., Mattei M. G., Hayashi M. and Olsen B. R. (1994) Gene encoding a novel murine tissue inhibitor of melalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, curtilage, and muscle, and is located on mouse chromosome 10. Dev. Dyn. 200: 177-197
21. 21 Sun Y., Hegamyer G., Kim H., Sithanandam K., Li H., Watts R. et al. (1995) Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter: specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation. J. Biol. Chem. 270: 19312-19319
22. 22 Greene J., Wang M., Liu Y. E., Raymond L. A., Rosen C. and Shi Y. E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380
23. 23 Leco K. J., Apte S. S., Taniguchi G. T., Hawkes S. P., Khokha R., Schultz G. A. et al. (1997) Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett. 401: 213-217
24. 24 Fata J. E., Leco K. J., Moorehead R. A., Martin D. C. and Khokha R. (1999) Timp-1 is important for epithelial proliferation and branching morphogenesis during mammary development. Dev. Biol. 211: 238-254
25. 25 Inderdeo D. S., Edwards D. R., Han V. K. and Khokha R. (1996) Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse. Biol. Reprod. 55: 498-508
26. 26 Water-house P., Denhardt D. T. and Khokha R. (1993) Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol. Reprod. Dev. 35: 219-226
27. 27 Tsafriri A. (1995) Ovulation as a tissue remodeling process. In: Tissue Renin-Angiotensin Systems, pp. 121-140, Mukhophadhyay A. K. and Raizada M. K. (eds), Plenum, New York
28. 28 Monniaux D., Huet C., Besnard N., Clement F., Bosc M., Pisselet C. et al. (1997) Follicular growth and ovarian dynamics in mammals. J. Reprod. Fertil. Suppl. 51: 3-23
29. 29 Hirshfield A. N. (1991) Development of follicles in the mammalian ovary. Int. Rev. Cytol. 124: 43-101
30. 30 Fortune J. E. (1994) Ovarian follicular growth and development in mammals. Biol. Reprod. 50: 225-232
31. 31 Bjersing L. and Cajander S. (1974) Ovulation and the mechanism of follicle rupture. V. Ultrastructure of tunica albuginea and theca externa of rabbit graafum follicles prior to induced ovulation. Cell Tissue Res. 153: 15-30
32. 32 Bjersing L. and Cajander S. (1974) Ovulation and the mechanism of follicle rupture. VI. Ultrastructure of theca interna and the inner vascular network surrounding rabbit graafian follicles prior to induced ovulation. Cell Tissue Res. 153: 31-44
33. 33 Schochet S. S. (1916) A suggestion as to the process of ovulation and ovarian cyst formation. Anat. Rec. 10: 447-457
34. 34 Espey L. L. (1967) Ultrastructure of the apex of the rabbit graafian follicle during the ovulatory process. Endocrinology 81: 267-276
35. 35 Reich R., Miskin R. and Tsafriri A. (1985) Follicular plasminogen activator: involvement in ovulation. Endocrinology 116: 516-521
36. 36 Reich R., Miskin R. and Tsafriri A. (1986) Intrafollicular distribution of plasminogen activators and their hormonal regulation in vitro. Endocrinology 119: 1588-1593
37. 37 Canipari R., O'Connell M. L., Meyer G. and Strickland S. (1987) Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator. J. Cell. Biol. 105: 977-981
38. 38 Beers W. H., Strickland S. and Reich E. (1975) Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell 6: 387-394
39. 39 Hirsch B., Leonhardt S., Jarry H., Reich R., Tsafriri A. and Wuttke W. (1993) In vivo measurement of rat ovarian collagenolytic activities. Endocrinology 133: 2761-2765
40. 40 Curry T. B. J., Clark M. R., Dean D. D., Woessner J. F. J. and LeMaire W. J. (1986) The preovulatory increase in ovarian collagenase activity in the rat is independent of prostaglandin production. Endocrinology 118: 1823-1828
41. 41 Espey L. L. and Lipner H. (1994) Ovulation. In: The Physiology of Reproduction, pp. 725-780, Knobil E. and Neill J. D. (eds), Raven, New York
42. 42 Ichikawa S., Morioka H., Ohta M., Oda K. and Murao S. (1983) Effect of various proteinase inhibitors on ovulation of explanted hamster ovaries. J. Reprod. Fertil. 68: 407-412
43. 43 Tsafriri A., Bicsak T. A., Cajander S. B., Ny T. and Hsueh A. J. (1989) Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. Endocrinology 124: 415-421
44. 44 Brannstrom M., Woessner J. F. J., Koos R. D., Sear C. H. and LeMaire W. J. (1988) Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary. Endocrinology 122: 1715-1721
45. 45 Katz E. (1988) The luteinized unruptured follicle and other ovulatory dysfunctions. Fertil. Steril. 50: 839-850
46. 46 Moor R. M. and Crosby I. M. (1987) Cellular origin, hormonal regulation and biochemical characteristics of polypeptides secreted by graafian follicles of sheep. J. Reprod. Fertil. 79: 469-483
47. 47 Curry T. E. J., Sanders S. L., Pedigo N. G., Estes R. S., Wilson E. A. and Vernon M. W. (1988) Identification and characterization of metalloproteinase inhibitor activity in human ovarian follicular fluid. Endocrinology 123: 1611-1618
48. 48 Mann J. S., Kindy M. S., Edwards D. R. and Curry T. E. J. (1991) Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries. Endocrinology 128: 1825-1832
49. 49 Zhu C. and Woessner J. F. J. (1991) A tissue inhibitor of metalloproteinases and alpha-macroglobulins in the ovulating rat ovary: possible regulators of collagen matrix breakdown. Biol. Reprod. 45: 334-342
50. 50 Curry T. E. J., Mann J. S., Estes R. S. and Jones P. B. (1990) Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries. Endocrinology 127: 63-68
51. 51 Reinthaller A., Kirchheimer J. C., Deutinger J., Bieglmayer C., Christ G. and Binder B. R. (1990) Plasminogen activators, plasminogen activator inhibitor, and fibronectin in human granulosa cells and follicular fluid related to oocyte maturation and intrafollicular gonadotropin levels. Fertil. Steril. 54: 1045-1051
52. 52 Smith G. W., McCrone S., Petersen S. L. and Smith M. F. (1995) Expression of messenger ribonucleic acid encoding tissue inhibitor of metalloproteinases-2 within ovine follicles and corpora lutea. Endocrinology 136: 570-576
53. 53 Nothnick W. B., Soloway P. and Curry T. E. J. (1997) Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. Biol. Reprod. 56: 1181-1188
54. 54 Boujrad N., Ogwuegbu S. O., Gamier M., Lee C. H., Martin B. M. and Papadopoulos V. (1995) Identification of a stimulator of steroid hormone synthesis isolated from testis. Science 268: 1609-1612 [published erratum appears in Science (1995) 270: 365]
55. 55 Nothnick W. B., Edwards D. R., Leco K. J. and Curry T. E. J. (1995) Expression and activity of ovarian tissue inhibitors of metalloproteinases during pseudopregnancy in the rat. Biol. Reprod. 53: 684-691
56. 56 Endo T., Aten R. F., Wang F. and Behrman H. R. (1993) Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis. Endocrinology 133: 690-698
57. 57 Smith G. W., Goetz T. L., Anthony R. V. and Smith M. F. (1994) Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: ontogeny of messenger ribonucleic acid expression and in situ localization within preovulatory follicles and luteal tissue. Endocrinology 134: 344-352
58. 58 Woessner J. F. J., Morioka N., Zhu C., Mukaida T., Butler T. and LeMaire W. J. (1989) Connective tissue breakdown in ovulation. Steroids 54: 491-499
59. 59 Paavola L. G. (1979) The corpus luteum of the guinea pig. IV. Fine structure of macrophages during pregnancy and postpartum luteolysis, and the phagocytosis of luteal cells. Am. J. Anal. 154: 337-364
60. 60 Curry T. E. J., Mann J. S., Huang M. H. and Keeble S. C. (1992) Gelatinase and proteoglycanase activity during the periovulatory period in the rat. Biol. Reprod. 46: 256-264
61. 61 Juengel J. L., Smith G. W., Smith M. F., Youngquist R. S. and Garverick H. A. (1994) Pattern of protein production by bovine corpora lutea during luteolysis and characterization of expression of two major secretory products of regressing corpora lutea. J. Reprod. Fertil. 100: 515-520
62. 62 Duncan W. C., Illingworth P. J. and Fraser H. M. (1996) Expression of tissue inhibitor of metalloproteinases-1 in the primate ovary during induced luteal regression. J. Endocrinol. 151: 203-213
63. 63 Duncan W. C., McNeilly A. S. and Illingworth P. J. (1996) Expression of tissue inhibitor of metalloproteinases-1 in the human corpus luteum after luteal rescue. J. Endocrinol. 148: 59-67
64. 64 Freudenstein J., Wagner S., Luck R. M., Einspanier R. and Scheit K. H. (1990) mRNA of bovine tissue inhibitor of metalloproleinase: sequence and expression in bovine ovarian tissue. Biochem. Biophys. Res. Commun. 171: 250-256
65. 65 Tanaka T., Andoh N., Takeya T. and Sato E. (1992) Differential screening of ovarian cDNA libraries detected the expression of the porcine collagenase inhibitor gene in functional corpora lutea. Mol. Cell. Endocrinol. 83: 65-71
66. 66 Piver M. S., Baker T. R., Piedmonte M. and Sandecki A. M. (1991) Epidemiology and etiology of ovarian cancer. Semin. Oncol. 18: 177-185
67. 67 Buckley C. H. and Fox J. (1986) Histophathological aspects of ovarian cancer. In: Management of Ovarian Cancer, pp. 5-14, Blackledge G. and Chan K. K. (eds), Butterworlh, London
68. 68 Tamakoshi K., Kikkawa F., Nawa A., Maeda O., Kawai M., Sugamuma N. et al. (1994) Different pattern of zymography between human gynecologic normal and malignant tissues. Am. J. Obstet.Gynecol. 171: 478-484
69. 69 Kikkawa F., Tamakoshi K., Nawa A., Shibata K., Yamagata S., Yamagata T. et al. (1997) Positive correlation between inhibitors of matrix mctalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues. Cancer Lett. 120: 109-115
70. 70 Takemura M., Azuma C., Kimura T., Kanai T., Saji F. and Tanizawa O. (1994) Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues. Int. J. Gynaecol. Obstet. 46: 303-309
71. 71 Ferrante K., Winograd B. and Canetta R. (1999) Promising new developments in cancer chemotherapy. Cancer Chemother. Pharmacol. 43 (Suppl.): S61-S68
72. 72 Zhang J. and Salamonsen L. A. (1999) Tissue inhibitor of metalloproteinases (TIMP)-1, -2, and -3 in human endometrium during the menstrual cycle. Mol. Hum. Reprod. 3: 735-741
73. 73 Carr B. R. (1992) Disorders of the ovary and female reproductive tract. In: Williams Textbook of Endocrinology, pp. 733-798, Wilson J. D. and Foster D. W. (eds), Saunders, Philadelphia
74. 74 Rodgers W. H., Matrisian L. M., Giudice L. C., Dsupin B., Cannon P., Svitek C. et al. (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 94: 946-953
75. 75 Irwin J. C., Kirk D. and Gwatkin R. B. L. (1996) Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. J. Clin. Invest. 97: 438-447
76. 76 Jeziorska M., Nagase H., Salamonsen L. A. and Woolley D. E. (1996) Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin-1 in human endometrium throughout the menstrual cycle. J. Reprod. Fertil. 107: 43-51
77. 77 Rodgers W. H., Osleen K. G. and Matrisian L. M. (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproduction cycle. Am. J. Obstet. Gynecol. 168: 253-260
78. 78 Hampton A. L., Butt A. R., Riley S. C. and Salamonsen L. A. (1995) Tissue inhibitors of metalloproteinases in endometrium of ovariectomized steroid-treated ewes and during the estrous cycle and early pregnancy. Biol. Reprod. 53: 302-311
79. 79 Hampton A. L. and Salamonsen L. A. (1994) Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J. Endocrinol. 141: R1-R3
80. 80 Marbaix E., Kokorine I., Henriet P., Donnez J., Courtoy P. J. and Eeckhout Y. (1995) The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem. J. 305: 1027-1030
81. 81 Kokorine I., Marbaix E. and Henriet P. (1996) Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinas-1) are related to menstrual breakdown in the human endometrium. J. Cell Sci. 109: 2151-2160
82. 82 Brenner R. M., Rudolph L., Matrisian L. and Slayden O. D. (1996) Non-human primate models: artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts. Hum. Reprod. 11(Suppl. 2): 150-164
83. 83 Salamonsen L. A. and Woolley D. E. (1996) Matrix metalloproteinases in normal menstruation. Hum. Reprod. 11(Suppl. 2): 124-133
84. 84 Higuchi T., Kanzaki H., Nakayama H., Fujimoto M., Hatayama H., Kojima K. et al. (1995) Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells. Endocrinology 136: 4973-4981
85. 85 Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y. and Courtoy P. J. (1996) Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc. Natl. Acad. Sci. USA 93: 9120-9125
86. 86 Salamonsen L. A., Butt A. R., Hammond E. R., Garcia S. and Zhang J. (1997) Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J. Clin. Endocrinol. Metab. 82: 1409-1415
87. 87 Tyree B., Halme J. and Jeffrey J. J. (1980) Latent and active forms of collagenase in rat uterine expiant cultures: regulation of conversion of progestational steroids. Arch. Biochem. Biophys. 202: 314-317
88. 88 Marbaix E., Donnez J., Courtoy P. J. and Eeekhout Y. (1992) Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. USA 89: 11789-11793
89. 89 Martelli M., Campana A. and Bischof P. (1993) Secretion of matrix metalloproteinases by human endometrial cells in vitro. J. Reprod. Fertil. 98: 67-76
90. 90 Schatz F., Papp C., Toth-Pal E. and Lockwood C. J. (1994) Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J. Clin. Endocrinol. Metab. 78: 1467-1472
91. 91 Osteen K. G., Rodgers W. H. and Gaire M. (1994) Stromalepithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl. Acad. Sci. USA 91: 10129-10133
92. 92 Bruner K. L., Rodgers W. H. and Gold L. I. (1995) Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl. Acad. Sci. USA 92: 7362-7366
93. 93 Jeffrey J. J., Coffey R. J. and Eisen A. Z. (1971) Studies on uterine collagenase in tissue culture, II. Effect of steroid hormones on enzyme production. Biochim. Biophys. Acta 252: 143-149
94. 94 Kastner P., Krust A. and Turcotte B. (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9: 1603-1614
95. 95 Murphy G., Stanton H., Cowell S., Butler G., Knauper V., Atkinson S. et al. (1999) Mechanisms for pro matrix metalloproteinase activation. APMIS 107: 38-44
96. 96 Clark D. A. (1992) Cytokines in uterine bleeding. In: Steroid Hormones and Uterine Bleeding, pp. 263-275, Alexander N. J. and d'Arcangues C. (eds), American Association for the Advancement of Science, Washington
97. 97 Bulmer J. N., Hellings D. and Ritson A. (1987) Immunocytochemical evidence that endometrial stromal granulocytes are granulated lymphocytes. J. Pathol. 153: 281-288
98. 98 Markee J. E. (1940) Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib. Embryol. 177: 220-320
99. 99 Snell G. D., Bronson F. H. and Dagg C. P. (1966) Reproduction. In: The Biology of the Laboratory Mouse, pp. 187-204, Green E. L. (ed.), Dover, New York
100. 100 Woessner J. Jr and Taplin C. (1988) Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J. Biol. Client. 263: 16918-16925
101. 101 Rudolph-Owen L. A., Hulboy D. L., Wilson C. L., Mudgett J. and Matrisian L. M. (1997) Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 138: 4902-4911
102. 102 Sellers A. and Woessner J. F. Jr (1980) The extraction of a neutral metalloproteinase from th involuting rat uterus and its action on cartilage proteoglycan. Biochem. J. 189: 521-531
103. 103 Yagel S., Parhar R. S., Jeffrey J. J. and Lala P. K. (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J. Cell. Physiol. 136: 455-462
104. 104 Graham C. H. and Lala P. K. (1991) Mechanism of control of trophoblast invasion in situ. J. Cell. Physiol. 148: 228-234
105. 105 Cross J. C., Werb Z. and Fisher S. J. (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266: 1508-1518
106. 106 Damsky C. H. and Fisher S. J. (1998) Trophoblast pseudovasculogenesis: taking it with endothelial adhesion receptors. Curr. Opin. Cell Biol. 10: 660-666
107. 107 Glass R. H., Aggeler J., Spindle A., Pedersen R. A. and Werb Z. (1983) Degradation of extracellular matrix by mouse trophoblast outgrowths: a model for implantation. J. Cell Biol. 96: 1108-1116
108. 108 Brenner C. A., Adler R. R., Rappolee D. A., Pedersen R. A. and Werb Z. (1989) Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev. 3: 848-859
109. 109 Behrendtsen O., Alexander C. M. and Werb Z. (1992) Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114: 447-456
110. 110 Harvey M. B., Leco K. J., Arcellana-Panlilio M. Y., Zhang X., Edwards D. R. and Schultz G. A. (1995) Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 121: 1005-1014
111. 111 Reponen P., Leivo I., Sahlberg C., Apte S. S., Olsen B. R., Thesleff I. et al. (1995) 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev. Dyn. 202: 388-396
112. 112 Leco K. J., Edwards D. R. and Schultz G. A. (1996) Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus. Mol. Reprod. Dev. 45: 458-465
113. 113 Alexander C. M., Hansell E. J., Behrendtsen O., Flannery M. L., Kishnani N. S., Hawkes S. P. et al. (1996) Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122: 1723-1736
114. 114 Das S. K., Yano S., Wang J., Edwards D. R., Nagase H. and Dey S. K. (1997) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ulerus during the peri-implantation period. Dev. Genet. 21: 44-54
115. 115 Stewart C. L., Kaspar P., Brunet L. J., Bhatt H., Gadi I., Konigen F. et al. (1992) Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359: 76-79
116. 116 Bhatt H., Brunet L. J. and Stewart C. L. (1991) Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc. Natl. Acad. Sci. USA 88: 11408-11412
117. 117 Yamamoto H., Flannery M. L., Kupriyanov S., Pearce J., McKercher S. R., Henkel G. W. et al. (1998) Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12: 1315-1326
118. 118 Rinkenberger J. L., Cross J. C. and Werb Z. (1997) Molecular genetics of implantation in the mouse. Dev. Genet. 21: 6-20
119. 119 Vu T. H., Shipley J. M., Bergers G., Berger J. E., Helms J. A., Hanahan D. et al. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422
120. 120 Lefebvre O., Regnier C., Chenard M. P., Wendling C., Chambon P., Basset P. et al. (1995) Developmental expression of mouse stromelysin-3 mRNA. Development 121: 947-955
121. 121 Masson R., Lefebvre O., Noel A., Fahime M. E., Chenard M. P., Wendling C. et al. (1998) In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140: 1535-1541
122. 122 Tanaka S. S., Togooka Y., Sato H., Seiki M., Tojo H. and Tachi C. (1998) Expression and localization of membrane type matrix metalloproteinase-1 (MT1-MMP) in trophoblast cells of cultured mouse blastocysts and cetoplacental cones. Placenta 19: 41-48
123. 123 Kirby D. R. S. (1960) Development of mouse eggs beneath the kidney capsule. Nature 187: 707-708
124. 124 Librach C. L., Werb Z., Fitzgerald M. L., Chiu K., Corwin N. M., Esteves R. A. et al. (1991) 92-kD type IV collagenase mediates invasion of human cytotrophoblasls. J. Cell Biol. 113: 437-449
125. 125 Higuchi T., Kanzaki H., Nakayama H., Fujimoto M., Hatayama H., Kojima K. et al. (1995) Induction of tissue inhibitor of metalloproteinase .3 gene expression during in vitro decidualization of human endometrial stromal cells. Endocrinology 136: 4973-4981
126. 126 Lockwood C. J., Krikun G., Hausknecht V. A., Papp C. and Sehatz F. (1998) Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiatcd decidualization and menstruation-related progestin withdrawal. Endocrinology 139: 4607-4613
127. 127 Tamada H., McMaster M. T., Flanders K. C., Andrews G. K. and Dey S. K. (1990) Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period. Mol. Endocrinol. 4: 965-972
128. 128 Roelen B. A., Lin H. Y., Knezevic V., Freund E. and Mummery C. L. (1994) Expression of TGF-betas and their receptors during implantation and organogenesis of the mouse embryo. Dev. Biol. 166: 716-728
129. 129 Huang H. Y., Wen Y., Irwin J. C., Kruessel J. S., Soong Y. K. and Polan M. L. (1998) Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 83: 1721-1729
130. 130 Ahonen M., Baker A. H. and Kahari V. M. (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58: 2310-2315
131. 131 Bian J., Wang Y., Smith M. R., Kim H., Jacobs C., Jackman J. et al. (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17: 1805-1811
132. 132 Baker A. H., Zaltsman A. B., George S. J. and Newby A. C. (1998) Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro: TIMP-3 promotes apoptosis. J. Clin. Invest. 101: 1478-1487
133. 133 Smith M. R., Kung H., Durum S. K., Colburn N. H. and Sun Y. (1997) TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 9: 770-780
134. 134 Fisher S. J., Cui T. Y., Zhang L., Hartman L., Grahl K., Zhang G. Y. et al. (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J. Cell Biol. 109: 891-902
135. 135 Shimonovitz S., Hurwitz A., Dushnik M., Anteby E., Geva-Eldar T. and Yagel S. (1994) Developmental regulation of the expression of 72 and 92 kD type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am. J. Obstet. Gynecol. 171: 832-838
136. 136 Bass K. E., Li H., Hawkes S. P., Howard E., Bullen E., Vu T. K. et al. (1997) Tissue inhibitor of metalloproteinase-3 expression is upregulated during human cytotrophoblast invasion in vitro. Dev. Genet. 21: 61-67
137. 137 Sharma R. K. (1998) Mouse trophoblastic cell lines. I. Relationship between invasive potential and TGF-beta 1. In Vivo 12: 431-440
138. 138 Librach C. L., Feigenbaum S. L., Bass K. F., Cui T. Y., Verastas N., Sadovsky Y. et al. (1994) Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J. Biol. Chem. 269: 17125-17131
139. 139 Simon C., Frances A., Piquette G. N., el Danasouri I., Zurawski G., Dang W. and Polan M. L. (1994) Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 134: 521-528
140. 140 Shimonovitz S., Hurwitz A., Hochner-Celnikier D., Dushnik M., Anteby E. and Yagel S. (1998) Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. Am. J. Obstet. Gynecol. 178: 457-461
141. 141 Roth I., Corry D. B., Locksley R. M., Abrams J. S., Litton M. J. and Fisher S. J. (1996) Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J. Exp. Med. 184: 539-548
142. 142 Roth I. and Fisher S. J. (1999) IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev. Biol. 205: 194-204
143. 143 Graham C. H., Connelly I., MacDougall J. R., Kerbel R. S., Stetler-Stevenson W. G. and Lala P. K. (1994) Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp. Cell Res. 214: 93-99
144. 144 Graham C. H., Lysiak J. J., McCrae K. R. and Lala P. K. (1992) Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol. Reprod. 46: 561-572
145. 145 Khoo N. K., Bechberger J. F., Shepherd T., Bond S. L., McCrae K. R., Hamilton G. S. et al. (1998) SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFbeta. Int. J. Cancer 77: 429-439
146. 146 Nomura S., Hogan B. L., Wills A. J., Heath J. K. and Edwards D. R. (1989) Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development 105: 575-583
147. 147 Blavier L. and DeClerck Y. A. (1997) Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development. Mol. Biol. Cell 8: 1513-1527
148. 148 Zeng Y., Rosborough R. C., Li Y., Gupta A. R. and Bennett J. (1998) Temporal and spatial regulation of gene expression mediated by the promoter for the human tissue inhibitor of metalloproteinases-3 (TIMP-3)-encoding gene. Dev. Dyn. 211: 228-237
149. 149 Polette M., Nawrocki B., Pintiaux A., Massenat C., Maquoi E., Volders L. et al. (1994) Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab. Invest. 71: 838-846
150. 150 Hurskainen T., Hoyhtya M., Tuuttila A., Oikarinen A. and Autio-Harmainen H. (1996) mRNA expressions of TIMP-1, -2, and -3 and 92-kD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization. J. Histochem. Cytochem. 44: 1379-1388
151. 151 Nawrocki B., Polette M., Marchand V., Maquoi E., Beorchia A., Tournier J. M. et al. (1996) Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta 17: 565-572
152. 152 Vettraino I. M., Roby J., Tolley T. and Parks W. C. (1996) Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy. Placenta 17: 557-563
153. 153 Maquoi E., Polette M., Nawrocki B., Bischof P., Noel A., Pintiaux A. et al. (1997) Expression of stromelysin-3 in the human placenta and placental bed. Placenta 18: 277-285
154. 154 Bjorn S. F., Hastrup N., Lund L. R., Dano K., Larsen J. F. and Pyke C. (1997) Co-ordinated expression of MMP-2 and ils putative activator, MT1-MMP, in human placentation. Mol. Hum. Reprod. 3: 713-723
155. 155 Huppertz B., Kertschanska S., Demir A. Y., Frank H. G. and Kaufmann P. (1998) Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res. 291: 133-148
156. 156 Hurskainen T., Seiki M., Apte S. S., Syrjakallio-Ylitalo M., Sorsa T., Oikarinen A. et al. (1998) Production of membrane-type matrix metalloproteinase-1 (MT-MMP-1) in early human placenta: a possible role in placental implantation? J. Histochem. Cytochem. 46: 221-229
157. 157 Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E. et al. (1994) A matrix metalloprotcinase expressed on the surface of invasive tumour cells. Nature 370: 61-65
158. 158 Graham C. H. and McCrae K. R. (1996) Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am. J. Obstet. Gynecol. 175: 555-562
159. 159 Lim K. H., Zhou Y., Janatpour M., McMaster M., Bass K., Chun S. H. et al. (1997) Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am. J. Pathol. 151: 1809-1818
160. 160 Harkness M. L. R. and Harkness R. D. (1954) The collagen content of the reproductive tract of the rat during pregnancy and lactation. J. Physiol. 123: 492-500
161. 161 Woessner J. F. Jr (1962) Catabolism of collagen and non-collagen protein in the rat uterus during post-partum involution. Bioehem. J. 83: 304-314
162. 162 Woessner J. F. Jr (1996) Regulation of matrilysin in the rat uterus. Biochem. Cell Biol. 74: 777-784
163. 163 Mullins D. H. and Rorlich S. T. (1983) The role of proteinases in cellular invasion. Biochim. Biophys. Acta 695: 177-214
164. 164 Harkness R. D. and Moralee B. E. (1956) The time course and route of loss of collagen from the rat's uterus during post-partum involution. J. Physiol. 132: 502-508
165. 165 Silberstein G. B. and Daniel C. W. (1982) Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Dev. Biol. 90: 215-222
166. 166 Williams J. M. and Daniel C. W. (1983) Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol. 97: 274-290
167. 167 Witty J. P., Wright J. H. and Matrisian L. M. (1995) Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misrcgulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol, Biol. Cell 6: 1287-1303
168. 168 Talhouk R. S., Bissell M. J. and Werb Z. (1992) Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118: 1271-1282
169. 169 Sympson C. J., Talhouk R. S., Alexander C. M., Chin J. R., Clift S. M., Bissell M. J. et al. (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681-693 [published erratum appears in J. Cell Biol. (1996) 132: following 752]
170. 170 Thomasset N., Lochter A., Sympson C. J., Lund L. R., Williams D. R., Behrendtsen O. et al. (1998) Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am. J. Pathol. 153: 457-467
171. 171 Klein S., Roghani M. and Rifkin D. B. (1997) Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action. EXS 79: 159-192
172. 172 Bonewald L. F. (1999) Regulation and regulatory activities of transforming growth factor beta. Crit. Rev. Eukaryot. Gene Expr. 9: 33-44
173. 173 Gearing A. J., Beckett P., Christodoulou M., Churchill M., Clements J. M., Crimmin M. et al. (1995) Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukoc. Biol. 57: 774-777
174. 174 Fowlkes J. L., Thrailkill K. M., Serra D. M., Suzuki K. and Nagase H. (1995) Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proleinases. Prog. Growth Factor Res. 6: 255-263
175. 175 Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W. G. and Quaranta V. (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277: 225-228
176. 176 Ferguson D. J. and Anderson T. J. (1981) Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br. J. Cancer 44: 177-181
177. 177 Masters J. R., Drife J. O. and Scarisbrick J. J. (1977) Cyclic variation of DNA synthesis in human breast epithelium. J. Natl. Cancer Inst. 58: 1263-1265
178. 178 Lascelles A. K. and Lee C. S. (1978) Involution of the mammary gland. In: Lactation: a Comprehensive Treatise, pp. 115-177, Larson B. L. and Smith V. R. (eds), Academic Press, New York
179. 179 Warburton M. J., Mitchell D., Ormerod E. J. and Rudland P. (1982) Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, laclating, and involuting rat mammary gland. J. Histochem. Cytochem. 30: 667-676
180. 180 Martinez-Hernandez A., Fink L. M. and Pierce G. B. (1976) Removal of basement membrane in the involuting breast. Lab. Invest. 34: 455-462
181. 181 Sympson C. J., Talhouk R. S., Bissell M. J. and Werb Z. (1994) The role of metalloproteinases and their inhibitors in regulating mammary epithelial morphology and function in vivo. Perspect. Drug Disc. Des. 2: 401-411
182. 182 Alexander C. M., Howard E. W., Bissell M. J. and Werb Z. (1996) Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J. Cell Biol. 135: 1669-1677
183. 183 Quarric L. H., Addey C. V. and Wilde C. J. (1996) Programmed cell death during mammary tissue involution in duced by weaning, litter removal, and milk stasis. J. Cell Physiol. 168: 559-569
184. 184 Lefebvre O., Wolf C., Limacher J. M., Hutin P., Wendling C., LeMeur M. et al. (1992) The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J. Cell Biol. 119: 997-1002
185. 185 Heppner K. J., Matrisian L. M., Jensen R. A. and Rodgers W. H. (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149: 273-282
186. 186 Benaud C., Dickson R. B. and Thompson E. W. (1998) Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res. Treat. 50: 97-116
187. 187 Cockett M. I., Murphy G., Birch M. L., O'Connell J. P., Crabbe T., Millican A. T. et al. (1998) Matrix metalloproteinases and metastatic cancer. Biochem. Soc. Symp. 63: 295-313-
188. 188 Iwata H., Kobayashi S., Iwase H. and Okada Y. (1995) The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis. Nippon Rinsho 53: 1805-1810
189. 189 McCarthy K., Maguire T., McGreal G., McDermott E., O'Higgins N. and Duffy M. J. (1999) High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int. J. Cancer 84: 44-48
190. 190 Ree A. H., Florenes V. A., Berg J. P., Maelandsmo G. M., Nesland J. M. and Fodstad O. (1997) High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin. Cancer Res. 3: 1623-1628
191. 191 Hayakawa T., Yamashita K., Ohuchi E. and Shinagawa A. (1994) Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell Sci. 107: 2373-2379
192. 192 Hayakawa T., Yamashita K., Tanzawa K., Uchijima E. and Iwata K. (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: a possible new growth faetor in serum. FEBS Lett. 298: 29-32
193. 193 Brown P. D. (1998) Matrix metalloproteinase inhibitors. Breast Cancer Res. Treat. 52: 125-136
194. 194 Rasmussen H. S. and McCann P. P. (1997) Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimasuit. Pharmacol. Ther. 75: 69-75